Two of Astellas Pharma most sold products increase the risk of PRES in already vulnerable patients

Written by
Reviewed by

Posterior reversible encephalopathy syndrome (PRES) is an acute neurotoxic syndrome characterized by headache, impairment of consciousness, seizures, visual disturbances, and neurological deficits3. Long PRES can lead to death9;p3

Astellas Pharm...

Register to read the full analysis —or— Upgrade to access more features

#illnesses #side-effects #negative health #cancer #PRES

Actual Direct Impact

Assess the impact materiality of this Topic for Astellas Pharma

How negative/positive is the impact of Astellas Pharma for this Topic?

How would you rate the severity of this impact?

Scale (how grave the impact is)

Scope (how widespread the impact is)

Irremediability/Persistence (how difficult it is to counteract the impact)

Share this Analysis


Written by
Reviewed by

Keen to rectify an issue with this analysis?